John Houston

From big biopharma to biotech CEO, John Houston’s R&D journey highlights a fast-changing world
Endpoints
Wed, 09/20/17 - 09:23 am
R&D
John Houston
Big Pharma
biotech
Arvinas
GSK
Bristol-Myers Squibb